CCP
XBI icon

Clough Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Clough Capital Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-142,500
Closed -$10.6M – 103
2022
Q2 		$10.6M Buy
+142,500
New +$10.7M 1.31% 28

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Clough Capital Partners's XBI Position: Q1 2023 in Review

Clough Capital Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 215,800 shares — an estimated $17.9M sold.

Clough Capital Partners first reported a position in XBI in Q2 2022 and held it in 2 quarters. The position peaked at $17.9M in Q4 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

  • Clough Capital Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Clough Capital Partners sold 215,800 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $17.9M.
  • Clough Capital Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 2 quarters.
  • Clough Capital Partners's State Street SPDR S&P Biotech ETF position peaked at $17.9M in Q4 2022.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Clough Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.